Cargando…
Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
Autores principales: | Porta, Camillo, Ferrari, Alessandra, Czarnecka, Anna M., Szczylik, Cezary A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478711/ https://www.ncbi.nlm.nih.gov/pubmed/28680399 http://dx.doi.org/10.3389/fphar.2017.00329 |
Ejemplares similares
-
Choosing the right cell line for renal cell cancer research
por: Brodaczewska, Klaudia K., et al.
Publicado: (2016) -
Insulin-like growth factor-1 signaling in renal cell carcinoma
por: Tracz, Adam F., et al.
Publicado: (2016) -
Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model
por: Krawczyk, Krzysztof M., et al.
Publicado: (2018) -
Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013) -
Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in
Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)